Development of a loop-mediated isothermal amplification (LAMP)-based electrochemical test for rapid detection of SARS-CoV-2.
Devices
Diagnostic technique in health technology
Journal
iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038
Informations de publication
Date de publication:
15 Sep 2023
15 Sep 2023
Historique:
received:
06
02
2023
revised:
10
03
2023
accepted:
07
08
2023
medline:
4
9
2023
pubmed:
4
9
2023
entrez:
4
9
2023
Statut:
epublish
Résumé
Rapid, reliable, sensitive, portable, and accurate diagnostics are required to control disease outbreaks such as COVID-19 that pose an immense burden on human health and the global economy. Here we developed a loop-mediated isothermal amplification (LAMP)-based electrochemical test for the detection of SARS-CoV-2 that causes COVID-19. The test is based on the oxidation-reduction reaction between pyrophosphates (generated from positive LAMP reaction) and molybdate that is detected by cyclic voltammetry using inexpensive and disposable carbon screen printed electrodes. Our test showed higher sensitivity (detecting as low as 5.29 RNA copies/μL) compared to the conventional fluorescent reverse transcriptase (RT)-LAMP. We validated our tests using human serum and saliva spiked with SARS-CoV-2 RNA and clinical (saliva and nasal-pharyngeal) swab samples demonstrating 100% specificity and 93.33% sensitivity. Our assay provides a rapid, specific, and sensitive test with an electrochemical readout in less than 45 min that could be adapted for point-of-care settings.
Identifiants
pubmed: 37664622
doi: 10.1016/j.isci.2023.107570
pii: S2589-0042(23)01647-4
pmc: PMC10470312
doi:
Types de publication
Journal Article
Langues
eng
Pagination
107570Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
All affiliations are listed on the title page of the manuscript. All funding sources for this study are listed in the “acknowledgments” section of the manuscript. We, the authors and our immediate family members, have no financial interests to declare. We, the authors, and our immediate family members, have no positions to declare and are not members of the journal’s advisory board. We declare that we have a patent application in process related to this work.
Références
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
ACS Sens. 2022 Mar 25;7(3):730-739
pubmed: 35192340
RSC Adv. 2018 Oct 12;8(61):34954-34959
pubmed: 35547082
Nat Biotechnol. 2020 Jul;38(7):870-874
pubmed: 32300245
J Environ Chem Eng. 2022 Jun;10(3):107488
pubmed: 35251932
Diagnostics (Basel). 2022 Mar 28;12(4):
pubmed: 35453876
Front Public Health. 2020 Nov 26;8:596944
pubmed: 33324602
Front Cell Infect Microbiol. 2022 Apr 20;12:856553
pubmed: 35521217
Case Rep Infect Dis. 2021 Mar 31;2021:6629966
pubmed: 33833882
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
EBioMedicine. 2022 Jan;75:103736
pubmed: 34922321
Anal Chem. 2015 Oct 20;87(20):10268-74
pubmed: 26412581
Clin Infect Dis. 2013 Dec;57 Suppl 3:S139-70
pubmed: 24200831
Biosens Bioelectron. 2023 Feb 15;222:114987
pubmed: 36495722
Sci Rep. 2021 May 10;11(1):9859
pubmed: 33972644
Nat Microbiol. 2019 Jan;4(1):46-54
pubmed: 30546093
Front Mol Biosci. 2022 Feb 09;8:794961
pubmed: 35223985
Nucleic Acids Res. 2000 Jun 15;28(12):E63
pubmed: 10871386
Natl Sci Rev. 2022 Jun 03;9(8):nwac104
pubmed: 35992231
Crit Care. 2019 Jun 6;23(1):202
pubmed: 31171006
Virol J. 2022 May 2;19(1):77
pubmed: 35501862
Front Med (Lausanne). 2021 May 07;8:615099
pubmed: 34026773
Nat Commun. 2021 Feb 5;12(1):802
pubmed: 33547323
BMC Infect Dis. 2021 Oct 6;21(1):1037
pubmed: 34615472
Diagnostics (Basel). 2021 Sep 08;11(9):
pubmed: 34573987
Anal Chim Acta. 2015 Aug 26;890:60-82
pubmed: 26347168
Chem Eng Sci. 2022 Apr 6;251:117430
pubmed: 35043022
J Microbiol Immunol Infect. 2021 Apr;54(2):159-163
pubmed: 32265180
Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165878
pubmed: 32544429
Nucleic Acids Res. 2011 Mar;39(6):2367-77
pubmed: 21071421
J Virol. 2001 Dec;75(24):12359-69
pubmed: 11711626
Nat Rev Microbiol. 2021 Sep;19(9):547-548
pubmed: 34183821
ACS Cent Sci. 2021 Jun 23;7(6):963-972
pubmed: 34235257
Sci Rep. 2021 Jul 26;11(1):15176
pubmed: 34312441
Front Cell Infect Microbiol. 2021 Jun 29;11:653616
pubmed: 34268131
Front Med (Lausanne). 2021 Nov 17;8:779454
pubmed: 34869499
Microbiol Spectr. 2021 Dec 22;9(3):e0110821
pubmed: 34878310
Emerg Microbes Infect. 2022 Dec;11(1):978-987
pubmed: 35293849
Int J Mol Med. 2021 Jun;47(6):
pubmed: 33846767
Emerg Microbes Infect. 2020 Dec;9(1):2020-2029
pubmed: 32799618
Exploration (Beijing). 2022 Oct 12;2(6):20210216
pubmed: 36713024
Lancet Microbe. 2020 Nov;1(7):e300-e307
pubmed: 32964211
Biosens Bioelectron. 2019 Apr 1;130:315-321
pubmed: 30784985
Clin Microbiol Infect. 2021 Sep;27(9):1348.e1-1348.e7
pubmed: 33901668
Mater Des. 2022 Nov;223:111263
pubmed: 36275835
Expert Rev Mol Diagn. 2021 Jan;21(1):43-61
pubmed: 33474990
JAMA Netw Open. 2022 Jan 4;5(1):e2145669
pubmed: 35089353
Virus Res. 2020 Oct 15;288:198129
pubmed: 32822689
Nature. 2020 Aug;584(7819):22-25
pubmed: 32760050